Stock investor - being transparent about my investments as I build my personal wealth and pay off bills. Anything I say and do is not investment advice.
I don't talk about work on here much, but I run the finances for multiple entities. Let me tell you, #AI is a game changer if you allow it to be. AI will separate businesses over the next 2 years. If you don't learn it and use it, you will fall behind.
I've started a new way of investing. This will result in lower gains overall, as it will be much slower, but also result in lower losses too.
I am buying one share of several different stocks to diversify. I can only buy additional shares on red days and only sell on green days. I know, CRAZY! There's nothing complicated about this one, but working to build a solid portfolio over time. Also, I am still sitting with 3k shares of $LIDR and 3k of $CRDF.
Been sitting with $LIDR and $CRDF for awhile. $CRDF has been my baby for two years. Getting really close to mature data coming out on its Cancer treatment drug. $LIDR is being set up for long term success. They will be presenting at CES 2026 at beginning of January.
@cyder_tv If results are good I could realistically see a jump to $10-$15 range. After that buyout talks start and we could see that price target increase.
@AlexGoldenNBA While losing sucks to see, just imagine them getting AJ Dybantsa in the draft. Basically Siakam 2.0 but even better vision (in my opinion). You play small ball with Siakam at the 5, Dynamtsa 4, Nesmith 3, Mathurin 2, Hali 1....that team is winning a championship.
Call me crazy but I'm working on building a men's clothing store in a small county of 15k people. Reason?? There's no place for men of this county to shop besides wamart. Starting online but not dropshipping. Holding merch at home and will even personally deliver it. #menswear
Been a minute since Iβve update my positions:
Long story short - sold covered calls on $CRDF in middle of August and used the cash to buy $PGEN at $2.99.
I had been holding onto some $LIDR shares which were in a gain position so I sold those and bought back the $CRDF calls and bought more $PGEN shares at $3.28.
Sold more covered calls on $CRDF and used funds to buy more $PgEN shares at $3.32. Sold a few $PGEN shares at a gain to buy back the $CRDF calls. Sold a 1000 $CRDF shares to buy more $PGEN at $3.43. Then sold all $PGEN shares at $3.99. This eventually erased my loss on $CRDF.
I have since sold all of my remaining $CRDF and bought $LIDR and had purchased 1,884 shares of $ALLR at $1.26 and then sold those shares at $2.03.
I have purchased some $ULTY since then and also sit on 1500 shares of $LIDR
WOW that was a lot.
Now Iβm just trying to get educated on how others are looking at this , especially with me not having a medical background or invested too much in Bios - the results to some of the tumors is great but what Iβm hearing is thereβs not enough proof in the data provided to say that was from the medicine, and that the very same thing could have happened using SOC?
There were more stage 3 and 4 cancer patients on the 20 and 30mg than on the control group. How is everyone also ignoring how quick and effective it was on tumors, making a prolonged life or potential to remove possible? I feel like everyone is stuck on that ORR but ignoring the rest.
If Iβm a cancer patient and I see this trial or have the SOC, Iβm taking this one every day.